SEP 12, 2017 06:00 PM SGT

WEBINAR: A Case Study Review on Large-scale Manufacturing of Stem Cell Therapies

SPONSORED BY: TERUMO BCT
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Development and Project Manager MaSTherCell (Gosselies, Belgium)
    Biography
      After receiving a master's degree at the Université Louis-Pasteur in France, Amel Tounsi obtained her PhD in Immunology and Cellular Biology at UCL (Université catholique de Louvain) in Brussels. She then followed a post-doctoral fellowship at a German cancer research center where she worked on the establishment of in vivo models in mice to study the immune-regulatory activity of bone-marrow-derived mesenchymal stem cells. After her academic experience, she joined the research and development (R&D) department of Cardio3 Biosciences (now called Celyad), a Belgian biotech company developing a stem cell therapy for the treatment of chronic heart failure. Amel was involved in process improvement and developed release and potency assays. Her expertise in academia, R&D and the biotech industry was an asset for MaSTherCell, where she has worked as development and project manager since August 2014.

    Abstract:

    DATE: September 13, 2017 
    TIME:  9:00AM SGT 12:00PM AEDT

    OR

    DATE: September 12, 2017
    TIME: 6:00PM PDT

     

    To transform the promises of cell-based therapies into reality, a robust and scalable process is required to be compliant with cGMP regulations. From clinical to commercial manufacturing, processes need to produce progressively larger batches with consistent product quality. By accomplishing these processes, it can make affordable and sustainable therapies reach the market more quickly. Here we present a case study from the large scale development expansion of a process using human stem cells obtained from adult bone marrow.

    Learning Objectives:

    • An example of a process that was used to scale out an allogeneic cell therapy, based on a comprehensive look at a case study
    • The advantage of using bioreactors for cell therapy manufacturing

     


    Show Resources
    You May Also Like
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    NOV 18, 2019 07:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    DEC 10, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 10, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    Loading Comments...
    Show Resources